- Chair of Human Nutrition (Human Nutrition)
My research covers many aspects of Human Nutrition, encouraging molecular, clinical and public health. The main major focuses are on obesity/diabetes/cardiovascular risk, and on plant-food antioxidants; particularly new phenolics.
Several important international bodies have reviewed parts of my research between 2000-2005. Importantly, in 2001 the Adult Training Programme III of NIH Cholesterol Education Program published its authoritative diagnostic definition of Metabolic Syndrome, concluding that my research had established the case for making waist circumference a key component of diagnosis, and adopting the Action Level 2 cut-off values which I proposed for use in Health Promotion from my research. These waist circumference values are now used internationally, and by WHO. In 2006, the International Diabetes Federation adopted my Action Level 1 cut-offs for prevention of diabetes.
Founder member of the Counterweight Consortium with responsibility for design of the entire UK Counterweight Programme, and for its research programme. This output, with 5 original papers in international journals and over 20 presentations in US and Europe conferences, has led to adoption by NHS of the Counterweight Programme as the only led evidence-based intervention for obesity in Primary Care in UK. External grant income from 2000 has been in the region of £2,500,000.
Human Nutrition at Glasgow Royal Infirmary has a dedicated Clinical Trials Team, for clinical research (mainly obesity, diabetes, metabolic syndrome).